top of page
Pipeline
Pipeline
1. Structure based design approach for developing RNA modulatory compounds
​
2. Pre-cancer and cancer stem cell organoid bioreactor platforms for inhibitor screening
3. Hematopoietic stem cell bioreactor platform for therapeutic index and stem cell expansion assays
​
Other ADAR1 inhibitory strategies are under development
Aspera
Biomedicines
bottom of page